AAV gene therapy on cultured human iPSC-derived retina with loss of CRB1 and CRB2
Awardee: Jan Winjholds
Institution: Leiden University Medical Center (LUMC)
Award Amount: $50,312
Funding Period: February 1, 2019 - January 31, 2020
Previous
Previous
Targeting phagosome maturation to restore dysfunctional retinal pigmented epithelium in CHM
Next
Next